Locally Advanced Urothelial Cancer (DBCOND0113982)

Identifiers

Synonyms

Locally advanced Urothelial Cancer

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Enfortumab vedotin	An antibody-drug conjugate comprised of a fully human monoclonal antibody and microtubule-disrupting chemotherapeutic agent used in the treatment of advanced or metastatic urothelial cancer.	Cytochrome P450 3A4enzyme Nectin-4target ATP-dependent translocase ABCB1transporter

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT03679767	A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)	Retifanlimab	treatment	2	completed
NCT04839510	A Study of MRG002 in the Treatment of HER2-positive Unresectable Locally Advanced or Metastatic Urothelium Cancer	Trastuzumab vedotin	treatment	2	unknown_status